Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 26 de jun. de 2023 · The earliest known documentation of nasopharyngeal angiofibroma (NA) dates to Hippocrates in the fifth century B.C. Commonly referred to as juvenile nasopharyngeal angiofibroma (JNA), it is also known as juvenile angiofibroma (JAF), or fibromatous or angiofibromatous hamartoma of the nasal cavity.

  2. 2 de jul. de 2023 · A rare, vascular tumor of the nasopharynx that affects young men. Learn about its epidemiology, clinical presentation, pathology, staging, radiographic features, treatment and differential diagnosis.

  3. 15 de jul. de 2015 · Juvenile nasopharyngeal angiofibroma (JNA) is a benign neoplasm of the nasopharynx. It accounts for 0.5% of all head and neck tumors occurring in 1 of 150,000 individuals. Adolescents and young adults between 14 and 25 years are affected, and there is a distinct male predominance.

  4. El angiofibroma nasal juvenil es un tumor benigno de presentación infrecuente, que afecta a varones prepuberes y púberes predominantemente, altamente vascularizado lo que explica el sangrado nasal importante que acompaña la sintomatología de estos pacientes, y que puede devenir en complicaciones fatales durante el acto operatorio.

  5. 18 de ene. de 2018 · Early stage juvenile nasopharyngeal angiofibroma (JNA) has a distinct blood supply from the ipsilateral ECA, most commonly the internal maxillary artery, ascending pharyngeal, sphenopalatine artery, and descending palatine artery, which can easily be embolized.

  6. Nasopharyngeal angiofibroma is an angiofibroma also known as juvenile nasal angiofibroma, fibromatous hamartoma, and angiofibromatous hamartoma of the nasal cavity. It is a histologically benign but locally aggressive vascular tumor of the nasopharynx that arises from the superior margin of the sphenopalatine foramen and grows in the ...

  7. Learn about JNA, a rare benign tumor of the nasopharynx that affects adolescent boys. Find out the symptoms, diagnosis, treatment and outlook of this condition at Children's Hospital of Philadelphia.